Roth R A, Rubin R J
Drug Metab Dispos. 1976 Sep-Oct;4(5):460-7.
The flow dependency of hepatic hexobarbital metabolism was examined in the isolated perfused rat liver. At low flow rates (0.5-1.0 ml/min/g of liver) hexobarbital clearance was found to depend on perfusion fluid flow, whereas at higher flow rates drug clearnace approached flow independence. Calculation of the in vivo hepatic blood flow rate suggested that hexobarbital metabolism in vivo should be highly dependent upon flow. Blood flow in the conscious rat was measured by use of radiolabeled microspheres during acute exposure to levels of hypoxic hypoxia (lowered pO2) or carbon monoxide which resulted in equal alterations in arterial oxyhemoglobin content (approximately 65% oxyhemoglobin). Hypoxic hypoxia (8% O2) caused a massive redistribution of flow away from the splanchnic area, resulting in a 45% decrease in hepatic blood flow. Carbon monoxide (500 ppm) was without significant effect on hepatic blood flow. These data would appear to explain the relatively greater inhibitory potency of hypoxic hypoxia on drug metabolism in vivo, since drug delivery to the liver is depressed by hypoxic hypoxia but unaffected by carbon monoxide exposure.
在离体灌注大鼠肝脏中研究了肝内己巴比妥代谢的血流依赖性。在低流速(0.5 - 1.0毫升/分钟/克肝脏)时,发现己巴比妥清除率取决于灌注液流速,而在较高流速时药物清除率接近与流速无关。体内肝血流速率的计算表明,体内己巴比妥代谢应高度依赖于血流。在清醒大鼠急性暴露于低氧性缺氧(降低的pO2)或一氧化碳水平期间,使用放射性标记微球测量血流,这些暴露导致动脉氧合血红蛋白含量发生相同变化(约65%氧合血红蛋白)。低氧性缺氧(8% O2)导致血流从内脏区域大量重新分布,导致肝血流减少45%。一氧化碳(500 ppm)对肝血流无显著影响。这些数据似乎可以解释低氧性缺氧对体内药物代谢的抑制作用相对更强,因为低氧性缺氧会降低肝脏的药物输送,但一氧化碳暴露对其没有影响。